Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sugemalimab Injection

Approval Number

国药准字S20210053

Company辉瑞投资有限公司

Registration Date

December 20, 2021

Drug Information

Generic Name

舒格利单抗注射液

Trade Name

择捷美

Dosage Form

注射剂

Strength

600mg（20.0ml）/瓶

Drug Type

生物制品

Registration Date

December 20, 2021

Company Information

Applicant Company

Company Name辉瑞投资有限公司

Company Address

上海市南京西路1168号中信泰富广场36层

Manufacturing Company

Company Name无锡药明生物技术股份有限公司

Company Address

江苏省无锡市滨湖区马山梅梁路108号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy